Gene panel to guide antiseizure medication prescribing: Does the cost justify the benefits?
Sign Up to like & getrecommendations! Published in 2022 at "Epilepsia"
DOI: 10.1111/epi.17418
Abstract: Pharmacogenomics hold the potential to identify variants associated with adverse drug reactions and treatment efficacy of anti‐seizure medications. A model‐based cost‐utility analysis by Gordon and colleagues showed that genetically‐guided therapy costs more, yielded higher quality‐adjusted… read more here.
Keywords: guide antiseizure; antiseizure medication; cost; gene panel ... See more keywords